https://www.palb2.org/contact-palb2-interest-group/2025-03-22T18:37:02+00:00https://www.palb2.org/palb2-interest-group/a-study-of-cancer-risks-in-palb2-mutation-carriers/2025-03-22T18:31:32+00:00https://www.palb2.org/resources-palb2-partner-localizer-brca2/2025-03-22T18:37:39+00:00https://www.palb2.org/palb2-interest-group/palb2-gene/2025-03-22T18:29:47+00:00https://www.palb2.org/palb2-interest-group/palb2-mutation-and-cancer-risks/2025-03-22T18:30:32+00:00https://www.palb2.org/palb2-interest-group/2025-03-22T18:25:32+00:00https://www.palb2.org/publications-breast-cancer-risk-palb2/2025-09-14T15:21:49+01:00https://www.palb2.org/palb2-interest-group/faqs-brca1-palb2-study/2025-03-24T17:01:09+00:00https://www.palb2.org/cookie-and-privacy-policy/2015-08-21T15:19:26+01:00https://www.palb2.org/team/palb2-interest-group-team/2025-03-24T16:54:15+00:00https://www.palb2.org/team/our-collaborators/2025-03-24T17:07:53+00:00https://www.palb2.org/palb2-interest-group/send-us-data/2025-03-20T17:27:28+00:00https://www.palb2.org/team/2025-03-22T18:22:40+00:00https://www.palb2.org/team/palb2-interest-group/2025-03-22T18:35:22+00:00https://www.palb2.org/2025-03-24T10:29:32+00:00https://www.palb2.org/new-study-shows-that-parp-inhibitors-are-effective-in-palb2-related-breast-cancer/2026-03-07T21:09:02+00:00